These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2142429)

  • 1. The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension.
    Waldemar G; Ibsen H; Strandgaard S; Andersen AR; Rasmussen S; Paulson OB
    Am J Hypertens; 1990 Jun; 3(6 Pt 1):464-70. PubMed ID: 2142429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patients.
    Cutler NR; Sramek JJ; Luna A; Mena I; Brass EP; Kurtz NM; Brennan JJ
    Ann Pharmacother; 1996 Jun; 30(6):578-82. PubMed ID: 8792940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fosinopril on cardiac function in patients with hypertension. Radionuclide assessment of left ventricular systolic and diastolic performance.
    Zusman RM; Christensen DM; Higgins J; Boucher CA
    Am J Hypertens; 1992 Apr; 5(4 Pt 1):219-23. PubMed ID: 1534664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects.
    Duchin KL; Waclawski AP; Tu JI; Manning J; Frantz M; Willard DA
    J Clin Pharmacol; 1991 Jan; 31(1):58-64. PubMed ID: 1646240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fosinopril and hydrochlorothiazide in patients with mild to moderate hypertension.
    Forslund T; Franzén P; Backman R
    J Intern Med; 1991 Dec; 230(6):511-7. PubMed ID: 1836220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Mitch S; Powell JR; Petrillo W; Cushman DW
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):139-46. PubMed ID: 1696656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily fosinopril in the treatment of hypertension.
    Anderson RJ; Duchin KL; Gore RD; Herman TS; Michaels RS; Nichola PS; Nolen TM; Wolfson P; Wombolt DG; Zusman R
    Hypertension; 1991 May; 17(5):636-42. PubMed ID: 1827086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril.
    Leonetti G; Trimarco B; Collatina S; Tosetti A
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):230S-235S. PubMed ID: 9366278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.
    Oren S; Messerli FH; Grossman E; Garavaglia GE; Frohlich ED
    J Am Coll Cardiol; 1991 Apr; 17(5):1183-7. PubMed ID: 1826120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fosinopril and hydrochlorothiazide on cerebral perfusion in uncomplicated essential hypertension.
    Semplicini A; Simonella C; Meneghetti G; Chierichetti F; Serena L; Claroni F; Fazari G; Ferlin G; Pessina AC
    J Hypertens Suppl; 1993 Dec; 11(5):S372-3. PubMed ID: 8158428
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.
    Massien C; Azizi M; Guyene TT; Vesterqvist O; Mangold B; Ménard J
    Clin Pharmacol Ther; 1999 Apr; 65(4):448-59. PubMed ID: 10223783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension.
    Murdoch D; McTavish D
    Drugs; 1992 Jan; 43(1):123-40. PubMed ID: 1372856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition.
    Beaulieu M; Nadeau A; Lacourcière Y; Cléroux J
    Br J Clin Pharmacol; 1993 Oct; 36(4):331-8. PubMed ID: 12959311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomized controlled trial.
    Nazir FS; Overell JR; Bolster A; Hilditch TE; Lees KR
    Cerebrovasc Dis; 2005; 19(2):77-83. PubMed ID: 15608430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
    Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
    Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II.
    Pool JL
    Clin Ther; 1990; 12(6):520-33. PubMed ID: 2149674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension.
    Sullivan PA; Dineen M; Cervenka J; O'Connor DT
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):280S-283S. PubMed ID: 2970855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
    van Schaik BA; Geyskes GG; Dorhout Mees EJ
    Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.